Online Inquiry
Inquiry
JNJ-26481585 (Quisinostat)
Product Name: | JNJ-26481585 (Quisinostat) |
CAT#: | DEH-2312-LGZ-4 |
Package: | 5mg/10mg/50mg/100mg/10mM * 1mL in DMSO |
Datasheet |
Description
JNJ-26481585, also known as Quisinostat, is a pan-HDAC inhibitor with significant potency against HDAC1 (IC(50), 0.16 nmol/L).
Basic Information
Synonyms: | JNJ26481585 |
Application: | HDAC Inhibitor |
CAS Number: | 875320-29-9 |
Formula: | C21H26N6O2 |
Molecular Weight: | 394.5 |
SMILES: | CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO |
Target Info
HDAC1: | 0.11 nM (IC50) |
HDAC2: | 0.33 nM (IC50) |
HDAC11: | 0.37 nM (IC50) |
HDAC10: | 0.46 nM (IC50) |
HDAC5: | 3.69 nM (IC50) |
HDAC8: | 4.26 nM (IC50) |
HDAC3: | 4.86 nM (IC50) |
HDAC9: | 32.1 nM (IC50) |
HDAC6: | 76.8 nM (IC50) |
HDAC7: | 119 nM (IC50) |
Storage
|
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.